If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
JANUARY 2013
Pathways
THE CLINICAL TRIALS NETWORK NEWSLETTER
Table of
Contents
2 JSNM & SNMMI
Collaboration
CTN at a Glance
3 Biomarker Spotlight:
F-18-Florbetapir
4 Japanese Symposium
PET Image
Reconstruction Grant
5 2013 MWM Preview
CTN Webinars
DoD Prostate Cancer
Imaging Grant
DIA 2012 Annual
Meeting
6 Tech Talk: Strength in
Numbers
PK and Biodistribution
Sampling
7 Sharing IND Information
Tech Tip
8 Abstract Accepted for
DIA 2013
Save the Date
An investigational new drug
(IND) application is a request
for authorization from the
U.S. Food and Drug Administration (FDA) to
administer an investigational drug to humans
and be exempt from a law that
JANUARY 2013 Pathways
Do You Need an IND? Continued from page 1. These
bIoMaRKER SPOTLIGHT F-18-FLORBETAPIR:THE FIRST AM
In the NEWS CTN and SNMMI Have Strong Presence at
2013 MWM Preview CTN Collaborates on Two Unique C
Tech Talk: Strength in Numbers Marybeth Devine, C
Special FEATURE INvESTIGaTIoNal NEw DRuG (IND) Su
CTN/CMIIT Joint Session Proposal accepted for DIa